Source: Private Capital Journal

Spiderwort: Spiderwort announces US $2.5M seed financing led by Horizons Ventures | Private Capital Journal

Spiderwort raised US $2.5M seed funding from Horizons Ventures and members of Capital Angel Network, Break Off Capital, Anges Québec, U.S. syndicate. Patrick Zhang and Dane Bedward joined Charles M.

Read full article »

Spiderwort's Competitors | Spiderwort's News | Spiderwort's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Charles M. Cuerrier

CEO Approval Rating

86/100

Spiderwort is a Canada-based biotechnology company that develops and commercializes novel cellulose biomaterials for the treatment of soft tissue replacement.